These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 11820954

  • 1. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W, Jin G, Ye Y, Xia X, Wang A, Zhuang Y, Li G, Sun H, Wang Z, Lin M, Chen H, Li J, Dan Z, Zhang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [Abstract] [Full Text] [Related]

  • 2. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y, National Cooperation Group On Clinical Study Of Mycobacterium Vaccae Vaccine.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis.
    Katoch K, Singh P, Adhikari T, Benara SK, Singh HB, Chauhan DS, Sharma VD, Lavania M, Sachan AS, Katoch VM.
    Vaccine; 2008 Feb 26; 26(9):1228-34. PubMed ID: 18243430
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 26; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 8. [A controlled clinical study on the efficacy of recombinant human interleukin-2 in the treatment of pulmonary tuberculosis].
    Chu NH, Zhu LZ, Yie ZZ, Yuan SL, Wang JY, Xu JL, Ma LP.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep 26; 26(9):548-51. PubMed ID: 14521759
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Short-term effect of treatment protocol utilizing levofloxacin, pasiniazide and M. Vaccae on multi- drug resistant pulmonary tuberculosis].
    Zheng XM, Li SM, Xing BC.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May 26; 24(5):574-5, 578. PubMed ID: 15151838
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis.
    Dlugovitzky D, Notario R, Martinel-Lamas D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J.
    Immunotherapy; 2010 Mar 26; 2(2):159-69. PubMed ID: 20635925
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis.
    Patel N, Deshpande MM, Shah M.
    J Indian Med Assoc; 2002 Mar 26; 100(3):191-3. PubMed ID: 12408283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N, Yan B, Zhu L.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul 26; 21(7):388-91. PubMed ID: 11326873
    [Abstract] [Full Text] [Related]

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct 26; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.